Lunge (Neubildung)

Aus PlusPedia
Wechseln zu: Navigation, Suche
Entstehender Artikel
Siehe auch
Freie Übersichtsartikel

[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48]

Wichtige Übersichtsartikel
Medline Suchterm/ Synonyme
Was ist das
Struktur
Physiologie
Knockout
Transgen
Mutation
Polymorphismus
Genexpression
Inhibitoren
Agonisten

1 Bibliographie

  1. ↑ Second-line and third-line chemotherapy for lung cancer: use and cost. Am J Manag Care 14(5):297-306 (2008) PMID 18471034
  2. ↑ Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med 140(9):740-53 (2004) PMID 15126259
  3. ↑ Lung cancer screening: recommendation statement. Ann Intern Med 140(9):738-9 (2004) PMID 15126258
  4. ↑ A translational approach to lung cancer research: From EGFRs to Wnt and cancer stem cells. Ann Thorac Cardiovasc Surg 15(4):213-20 (2009) PMID 19763051
  5. ↑ Staging of lung cancer. Chest 133(3):593-5 (2008) PMID 18321899
  6. ↑ Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):324S-339S (2007) PMID 17873178
  7. ↑ Evidence for management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):314S-323S (2007) PMID 17873177
  8. ↑ Bronchioloalveolar lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):306S-13S (2007) PMID 17873176
  9. ↑ Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):290S-305S (2007) PMID 17873175
  10. ↑ Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):277S-289S (2007) PMID 17873174
  11. ↑ Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):266S-276S (2007) PMID 17873173
  12. ↑ Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):243S-265S (2007) PMID 17873172
  13. ↑ Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):234S-242S (2007) PMID 17873171
  14. ↑ Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):221S-233S (2007) PMID 17873170
  15. ↑ Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):202S-220S (2007) PMID 17873169
  16. ↑ Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):178S-201S (2007) PMID 17873168
  17. ↑ Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):161S-77S (2007) PMID 17873167
  18. ↑ Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):149S-160S (2007) PMID 17873166
  19. ↑ Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):131S-148S (2007) PMID 17873165
  20. ↑ Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):108S-130S (2007) PMID 17873164
  21. ↑ Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):94S-107S (2007) PMID 17873163
  22. ↑ Diagnostic surgical pathology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):78S-93S (2007) PMID 17873162
  23. ↑ Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):69S-77S (2007) PMID 17873161
  24. ↑ Long-term survivorship in lung cancer: a review. Chest 129(4):1088-97 (2006) PMID 16608961
  25. ↑ Malignant pleural mesothelioma: update, current management, and newer therapeutic strategies. Chest 126(4):1318-29 (2004) PMID 15486399
  26. ↑ Surgical treatment of malignant pleural mesothelioma: a review. Chest 123(2):551-61 (2003) PMID 12576380
  27. ↑ Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest 123(1 Suppl):97S-104S (2003) PMID 12527569
  28. ↑ Diagnosis of lung cancer: pathology of invasive and preinvasive neoplasia. Chest 117(4 Suppl 1):80S-89S (2000) PMID 10777460
  29. ↑ Advances in the treatment of malignant pleural mesothelioma. Chest 116(2):504-20 (1999) PMID 10453882
  30. ↑ Bronchoalveolar carcinoma: histopathologic study of evolution in a series of 105 surgically treated patients. Chest 113(2):391-5 (1998) PMID 9498957
  31. ↑ Natural history and epidemiology of malignant mesothelioma. Chest 103(4 Suppl):373S-376S (1993) PMID 8462328
  32. ↑ Diagnostic imaging of lung cancer. Eur Respir J 19(4):722-42 (2002) PMID 11999004
  33. ↑ The new World Health Organization classification of lung tumours. Eur Respir J 18(6):1059-68 (2001) PMID 11829087
  34. ↑ Pulmonary epithelioid haemangioendothelioma in 21 patients, including three with partial spontaneous regression. Eur Respir J 12(1):89-96 (1998) PMID 9701420
  35. ↑ Biological and immunological aspects of malignant mesothelioma. Eur Respir J 8(4):643-50 (1995) PMID 7664867
  36. ↑ Serum tumour markers in lung cancer: history, biology and clinical applications. Eur Respir J 7(1):186-97 (1994) PMID 8143820
  37. ↑ New molecularly targeted therapies for lung cancer. J Clin Invest 117(10):2740-50 (2007) PMID 17909619
  38. ↑ Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation. J Clin Pathol 59(8):790-800 (2006) PMID 16873561
  39. ↑ Pulmonary adenocarcinoma: review of 106 cases and proposed new classification. J Clin Pathol 40(2):125-35 (1987) PMID 3818979
  40. ↑ Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 83(5):584-94 (2008) PMID 18452692
  41. ↑ Small cell lung cancer. Mayo Clin Proc 83(3):355-67 (2008) PMID 18316005
  42. ↑ Current treatments for advanced stage non-small cell lung cancer. Proc Am Thorac Soc 6(2):233-41 (2009) PMID 19349493
  43. ↑ Adjuvant treatment of resected lung cancer. Proc Am Thorac Soc 6(2):194-200 (2009) PMID 19349488
  44. ↑ Preneoplastic lesions of the lung. Respir Res 3():20 (2002) PMID 11980589
  45. ↑ Mesenchymoma of the lung (so called hamartoma): a review of 154 parenchymal and endobronchial cases. Thorax 42(10):790-3 (1987) PMID 3321538
  46. ↑ Alveolar carcinoma: a review. Thorax 39(3):166-74 (1984) PMID 6324408
  47. ↑ Histological classification of lung cancer. Thorax 39(3):161-5 (1984) PMID 6324407
  48. ↑ Diffuse malignant mesothelioma: a review. West J Med 137(6):548-54 (1982) PMID 6761970

2 Andere Lexika

Abgerufen von „http://de.pluspedia.org/w/index.php?title=Lunge_(Neubildung)&oldid=41706“

Diesen Artikel melden!
Verletzt dieser Artikel deine Urheber- oder Persönlichkeitsrechte?
Hast du einen Löschwunsch oder ein anderes Anliegen? Dann nutze bitte unser Kontaktformular

PlusPedia Impressum
Diese Seite mit Freunden teilen:
Mr Wong Digg Delicious Yiggit wikio Twitter
Facebook


Bitte Beachte:
Sämtliche Aussagen auf dieser Seite sind ohne Gewähr.
Für die Richtigkeit der Aussagen übernimmt die Betreiberin keine Verantwortung.
Nach Kenntnissnahme von Fehlern und Rechtsverstößens ist die Betreiberin selbstverständlich bereit,
diese zu beheben.

Verantwortlich für jede einzelne Aussage ist der jeweilige Erstautor dieser Aussage.
Mit dem Ergänzen und Weiterschreiben eines Artikels durch einen anderen Autor
werden die vorhergehenden Aussagen und Inhalte nicht zu eigenen.
Die Weiternutzung und Glaubhaftigkeit der Inhalte ist selbst gegenzurecherchieren.


Typo3 Besucherzähler - Seitwert blog counter
java hosting vpn norway